Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 7/10/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Rick Doblin

Wrong Dr. Rick Doblin?

Executive Director

Multidisciplinary Association for Psychedelic Studies Inc
1215 Mission St.
Santa Cruz, California 95060
United States

Company Description: Furthermore, MAPS has been involved for the last decade in litigation against DEA for refusing to license Prof. Craker, UMass Amherst, to grow marijuana exclusively...   more

Employment History

Board Memberships and Affiliations


  • doctorate , Public Policy
    Harvard's Kennedy School of Government
  • Ph.D.
  • PhD
  • Ph.D.
    University of Kent
  • Ph.D. Click
  • Ph.D. and MAPS Clinical Research Associate Berra Yazar-Klosinski
  • Ph.D. MAPS
  • Ph.D.'s paper
  • PhD.
  • PhD Debates Drug Policy
    Irelands Trinity College
  • Mag Farr MD PhD
  • Miguel ngel Alczar PhD
  • PhD Interviewed
  • Ph.D.
    Heffter Research Institute
  • advanced degree , public policy
    Harvard's Kennedy School
  • Public Policy
    Harvard University
  • doctorate
    Harvards Kennedy School of Government
  • Ph.D. , public policy
    Harvard's Kennedy School of Government
  • Ph.D. , Clinical Research Associate Berra Yazar-Klosinski
  • Ph.D. , Public Policy
    Kennedy School of Government at Harvard University
  • Ph.D
  • Public Policy Ph.D.
    Harvard's Kennedy School of Government
  • Ph.D.
  • Ph.D's opening
  • Ph.D. Fall
193 Total References
Web References
"It permits the possibility of cures, ..., 24 May 2014 [cached]
"It permits the possibility of cures, whereas current psychiatric medications are about minimally reducing symptoms," said Rick Doblin, the Harvard-educated founder and executive director of MAPS.
They had no idea," Doblin said.
No scientist believes that it does that," Doblin said.
Doblin founded MAPS in Florida in 1986 - it still works off a supply of MDMA produced by Purdue University at that time - and for several years he was the only staffed
But Doblin's own academic career would later hit a wall. He had trouble finding a school willing to entertain his idea for psychedelic-related graduate studies.
"My whole life for 16 years had been in one direction and then I couldn't follow it up anymore. So I went home and smoked a joint," Doblin said. "Marijuana gives you a chance to see things from a broader framework. And I thought, 'The politics is in the way of the science.'"
In 1998, Doblin found a mentor at Harvard's Kennedy School of Government, and he now has a doctorate in public policy. He still lives in Boston - Doblin has never lived in Santa Cruz - but a large staff is here.
Newly schooled in the levers of power, Doblin began working the Food and Drug Administration at a time when research into psychedelics had basically flat-lined. He credits a mid-1990s staff change at the agency for allowing research to go forward.
"We were able to get our first study approved for MDMA," Doblin said.
"We work with the hardest cases on purpose," Doblin said.
When Doblin wanted to relocate here, his team found Ben Lomond first, later resettling in Santa Cruz.
Scientific Advisory Panel | Heffter Research Institute, 14 Nov 2013 [cached]
Rick Doblin, Ph.D., President, Multidisciplinary Association for Psychedelic Studies, Inc.
Staff, 24 Dec 2013 [cached]
Rick Doblin, Ph.D., Founder and Executive Director
Rick Doblin, Ph.D., Founder and Executive Director
Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard's Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his Master's thesis on a survey of oncologists about smoked marijuana vs. the oral THC pill in nausea control for cancer patients. His undergraduate thesis at New College of Florida was a 25-year follow-up to the classic Good Friday Experiment, which evaluated the potential of psychedelic drugs to catalyze religious experiences. He also conducted a thirty-four year follow-up study to Timothy Leary's Concord Prison Experiment. Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner.
"Our study paves the way for ..., 1 Mar 2014 [cached]
"Our study paves the way for research that could make marijuana into a federally approved prescription medicine for PTSD," says MAPS executive director Rick Doblin, Ph.D. "We worked for 22 years to get permission to purchase marijuana from NIDA's monopoly supply.
Rick Doblin, founder & ..., 6 June 2014 [cached]
Rick Doblin, founder & executive director of the Multidisciplinary Association for Psychedelic Studies or MAPS said, "No one would bid on this contract because first you'd have to give all of your product to NIDA, but then you also test seized marijuana that is used to arrest people. Most marijuana growers don't want to be a part of a group that wants to throw people in jail."
Doblin went on to explain that in his opinion the NIDA monopoly exists to keep medical marijuana from being legalized. For example, if a researcher uses NIDA pot for a cancer study and then has good results and the FDA approves it, the researcher is unable to sell that product to the cancer patient. It is only grown for research not for resale. Under those circumstances, a nightmare scenario emerges: being able to tell a cancer patient you have a remedy, but you're unable to give it to them. Doblin's group, along with Dr. Lyle Craker, a respected professor at the University of Massachusetts has fought long and hard for decades to break the monopoly.
However, Doblin said, "We've been working with Israel -- they are able to grow it for 50 cents a gram, Uruguay sets its price at $1 a gram, NIDA's price from years ago was $7.
However, Doblin isn't optimistic.
Other People with the name "Doblin":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.